Primary Peritoneal Carcinoma in a BRCA1/2-negative, PALB2-positive patient

• First reported case of PPC after BSO in a BRCA1/2-negative, PALB2-positive patient; • The PALB2 mutation and genetic counseling is discussed; • Multi-gene panel testing can benefit prognostic factors and targeted therapy.

Detalles Bibliográficos
Autores principales: Kahn, Ryan, Garcia-Soto, Arlene, Silva-Smith, Rachel, Pinto, Andre, George, Sophia H.L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4983106/
https://www.ncbi.nlm.nih.gov/pubmed/27547810
http://dx.doi.org/10.1016/j.gore.2016.08.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4983106/
https://www.ncbi.nlm.nih.gov/pubmed/27547810
http://dx.doi.org/10.1016/j.gore.2016.08.001

Ejemplares similares